American Society For Technion- Israel Institute Of Technology Inc

Programs: The joan and irwin jacobs technioncornell institute: a partnership between cornell university and the technion-israel institute of technology, the jacobs technioncornell institute is a key component of cornell tech, the world-class applied sciences campus that opened on new york citys roosevelt island in fall 2017. The jacobs institute is delivering a new kind of multidisciplinary education and research, dedicated to producing engineers, scientists and technology experts with real-world entrepreneurial experience. Students enrolled in the two-year master of science (m. S. ) in information systems program earn dual master's degrees concurrently - one from cornell and one from the technion - in connective media and health tech. Faculty, postdoctoral associates and graduate students pursue basic and applied research, in collaboration with industry partners. A priority is research on topics with potential for technology transfer to established companies, or to form the basis of entrepreneurial ventures - with an eye toward driving economic growth in nyc. The campus will also house an onsite startup incubator and accelerator space, as well as a technology transfer office to assist in obtaining patents and moving technology from the lab to the marketplace.

the alfred mann institute for biomedical development at the technion "(amit)" was established in 2006 to transform innovative technologies developed by technion researchers into medical devices, pharmaceuticals and biologics that contribute to improving human health worldwide. Amit screens and evaluates research projects with potential for commercial applications. Following positive feasibility studies, amit may assemble a team that can commercialize the science and lead preclinical and clinical activities.

the histopathology core and faculty project recruitment fund: battling cancer begins with the understanding that the disease is driven by a combination of genetic and epigenetic changes - the latter are part of cancer's adaptation to the microenvironment and response to therapy. With this complex set of biological, environmental and behavioral factors influencing cancer development and response to treatment, an effective approach to combating the disease must be multidisciplinary in nature, drawing on a full range of skills, expertise and tools. Bringing together multidisciplinary teams of leading medical doctors and scientists to collaborate with engineers from a variety of disciplines, the technion integrated cancer center (ticc) is combining basic discovery with clinical and translational research, to culminate in clinical trials. Ticc scientists are developing sensitive diagnostic tools to detect malignant lesions at an early stage, define their genetic and epigenetic changes, and use this information to create personalized therapies that will be delivered by novel devices/approaches designed to selectively carry drugs to the tumor site. The ticc is comprised of several research cores, including the histopathology core, which focuses on the real-time capture, collection and delivery of tumors removed in ticc-affiliated hospitals to a tumor bank for analysis of genetic and epigenetic changes. As part of the ticcs goal to develop expertise in a range of cancer-related disciplines, the center is recruiting young scientists and establishing and outfitting their laboratories. Recent recruits supported by the crown family foundation specialize in bioinformatics, and research on the gut microbiome and its role in disease.

research grants and programs (see sch. O, pg. 1)